Bioversys AG (BIOV) — Net Asset Quality Index
Bioversys AG (BIOV) has a Net Asset Quality Index of 66.0% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CHF90.64 Million minus total liabilities of CHF30.82 Million yields net assets of CHF59.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check BIOV asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bioversys AG Net Asset Quality Index Over Time (2024–2025)
This chart shows how Bioversys AG's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the index stands at 66.0%, representing net assets of CHF59.81 Million against total assets of CHF90.64 Million CHF. See BIOV working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Bioversys AG (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Bioversys AG from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BIOV stock market capitalisation.
| Year | Quality Index | Net Assets (CHF) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.0% | CHF59.81 Million | CHF90.64 Million | CHF30.82 Million | ▲ +35.4 pp |
| 2024 | 30.6% | CHF10.68 Million | CHF34.96 Million | CHF24.27 Million | — |